Phillip Sharp

(Dr. Phillip Sharp Ph.D.)

Currently holds positions in Alnylam Pharmaceuticals Inc, Syros Pharmaceuticals Inc and Vir Biotechnology Inc

Positions

Position Company Period
Independent Director Alnylam Pharmaceuticals Inc June 1, 2002 -
Independent Director Syros Pharmaceuticals Inc Dec. 1, 2012 -
Independent Director Vir Biotechnology Inc Jan. 1, 2017 -
Phillip Sharp's trades of Alnylam Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-24 2025-01-23
PS Planned sale
11,250 -100.0%
275.00
USD 3,093,750 		11,250 -100.0% 275.00 USD 3,093,750
2024-03-01 2024-02-29
PS Planned sale
516 -100.0%
156.54
USD 80,775 		516 -100.0% 156.54 USD 80,775
2024-03-01 2024-02-29
PS Planned sale
101 -16.4%
154.07
USD 15,561 		101 -16.4% 154.07 USD 15,561
2024-03-01 2024-02-29
PS Planned sale
1,906 -75.5%
153.62
USD 292,800 		1,906 -75.5% 153.62 USD 292,800
2024-03-01 2024-02-29
PS Planned sale
915 -26.6%
152.40
USD 139,446 		915 -26.6% 152.40 USD 139,446
2024-03-01 2024-02-29
PS Planned sale
13,557 -79.8%
151.43
USD 2,052,937 		13,557 -79.8% 151.43 USD 2,052,937
2024-03-01 2024-02-29
PS Planned sale
13,005 -43.4%
150.60
USD 1,958,553 		13,005 -43.4% 150.60 USD 1,958,553
2022-08-17 2022-08-15
PS Planned sale
715 -100.0%
232.81
USD 166,459 		715 -100.0% 232.81 USD 166,459
2022-08-17 2022-08-15
PS Planned sale
3,853 -84.3%
231.65
USD 892,547 		3,853 -84.3% 231.65 USD 892,547
2022-08-17 2022-08-15
PS Planned sale
16,186 -78.0%
230.71
USD 3,734,272 		16,186 -78.0% 230.71 USD 3,734,272
2022-08-17 2022-08-15
PS Planned sale
11,600 -35.9%
229.93
USD 2,667,188 		11,600 -35.9% 229.93 USD 2,667,188
2022-08-17 2022-08-15
PS Planned sale
1,218 -3.6%
228.33
USD 278,106 		1,218 -3.6% 228.33 USD 278,106
2022-08-17 2022-08-15
PS Planned sale
98 -0.3%
226.16
USD 22,164 		98 -0.3% 226.16 USD 22,164
2022-02-11 2022-02-09
PS Planned sale
30,000 -100.0%
150.00
USD 4,500,000 		30,000 -100.0% 150.00 USD 4,500,000
2020-11-30 2020-11-25
PS Planned sale
645 -0.3%
127.44
USD 82,199 		645 -0.3% 127.44 USD 82,199
2020-11-30 2020-11-25
PS Planned sale
2,117 -0.9%
126.16
USD 267,081 		2,117 -0.9% 126.16 USD 267,081
2020-11-30 2020-11-25
PS Planned sale
15,715 -6.2%
125.05
USD 1,965,161 		15,715 -6.2% 125.05 USD 1,965,161
2020-11-30 2020-11-25
PS Planned sale
11,523 -4.3%
124.30
USD 1,432,309 		11,523 -4.3% 124.30 USD 1,432,309
2020-02-13 2020-02-12
PS Planned sale
30,000 -11.3%
130.00
USD 3,900,000 		30,000 -11.3% 130.00 USD 3,900,000
2019-11-20 2019-11-18
PS Planned sale
810 -0.3%
92.66
USD 75,055 		810 -0.3% 92.66 USD 75,055
2019-11-20 2019-11-18
PS Planned sale
8,631 -3.5%
91.97
USD 793,793 		8,631 -3.5% 91.97 USD 793,793
2019-11-20 2019-11-18
PS Planned sale
5,559 -2.2%
91.17
USD 506,814 		5,559 -2.2% 91.17 USD 506,814
2019-04-17 2019-04-15
PS Planned sale
600 -0.3%
91.40
USD 54,840 		600 -0.3% 91.40 USD 54,840
2019-04-17 2019-04-15
PS Planned sale
400 -0.2%
89.97
USD 35,988 		400 -0.2% 89.97 USD 35,988
2019-04-17 2019-04-15
PS Planned sale
2,200 -0.9%
89.03
USD 195,866 		2,200 -0.9% 89.03 USD 195,866
2019-04-17 2019-04-15
PS Planned sale
11,800 -4.7%
87.86
USD 1,036,748 		11,800 -4.7% 87.86 USD 1,036,748
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
100,000 -17.3%
59.12
USD 5,911,690 		100,000 -17.3% 59.12 USD 5,911,690
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
100,000 -14.7%
58.53
USD 5,853,470 		100,000 -14.7% 58.53 USD 5,853,470
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
70,000 -9.4%
58.70
USD 4,108,979 		70,000 -9.4% 58.70 USD 4,108,979
2004-05-17 2004-05-14
US Biogen Inc (BIIB)
S Sale
24,100 -3.1%
58.41
USD 1,407,669 		24,100 -3.1% 58.41 USD 1,407,669
2004-05-14 2004-05-13
US Biogen Inc (BIIB)
S Sale
65,000 -100.0%
58.00
USD 3,770,000 		65,000 -100.0% 58.00 USD 3,770,000
2004-05-05 2004-05-05
US Biogen Inc (BIIB)
S Sale
50,000 -6.1%
59.00
USD 2,950,000 		50,000 -6.1% 59.00 USD 2,950,000
2004-05-05 2004-05-04
US Biogen Inc (BIIB)
S Sale
5,900 -0.7%
58.90
USD 347,510 		5,900 -0.7% 58.90 USD 347,510
2004-05-05 2004-05-04
US Biogen Inc (BIIB)
S Sale
23,000 -16.7%
59.00
USD 1,357,000 		23,000 -16.7% 59.00 USD 1,357,000
// ... existing code ...